MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/490/0.01/20.12.24 Share Price

Warrant

DE000MB33RM8

Market Closed - Börse Stuttgart 19:42:20 27/06/2024 BST
0.46 EUR +4.55% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/490/0.01/20.12.24
Current month-8.00%
1 month-29.23%
Date Price Change
27/06/24 0.46 +2.22%
26/06/24 0.45 +2.27%
25/06/24 0.44 -4.35%
24/06/24 0.46 0.00%
21/06/24 0.46 -6.12%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 07:42 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MB33RM
ISINDE000MB33RM8
Date issued 01/02/2023
Strike 490 $
Maturity 20/12/2024 (176 Days)
Parity 100 : 1
Emission price 1.26
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.52
Lowest since issue 0.3
Delta0.6x
Omega 5.719
Premium9.87x
Gearing9.5x
Moneyness 1.007
Difference Strike -3.96 $
Difference Strike %-0.81%
Spread 0.03
Spread %6.00%
Theoretical value 0.4850
Implied Volatility 32.42 %
Total Loss Probability 48.67 %
Intrinsic value 0.0303
Present value 0.4547
Break even 541.91 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
494 USD
Average target price
564.1 USD
Spread / Average Target
+14.21%
Consensus